Scan.com funds its US imaging network with $130M of debt against a $165M run rate
Only $90M of the $220M raise is equity. The $130M of borrowing from VerisFi Capital and Atempo Growth is a claim about how predictable revenue already looks in a market still booked by fax.
The Investor · Invest desk
What happened
- Scan.com raised $220 million in combined equity and debt to expand its medical imaging platform across the United States.
- The package splits into a $90 million equity round led by Noteus Partners and $130 million of debt facilities provided by VerisFi Capital and Atempo Growth.
- The company says it passed a $165 million annualised revenue run rate after doubling revenue over the past year, from $85 million the year before.
- Scan.com puts the US imaging market above $100 billion and says around 85% of scans are still booked by fax or telephone, with patients waiting weeks while some centres sit on idle scanner time.
- The money goes to expanding the US provider network and to API and agentic AI infrastructure that routes patients, schedules scans and delivers diagnostic results.
Why it matters
- What it limits constraint Interest and amortisation on $130 million rank ahead of network build, so a slow quarter gets paid for out of the expansion budget rather than out of investor patience.
- Who has to decide decision Capital aimed at integrations and routing is capital not aimed at owning scanners, which keeps Scan.com a price-taker on the very capacity it resells.
- Who's exposed exposure Digital health providers and health plans that replace per-facility integrations with one API inherit Scan.com's provider coverage as a single dependency for their diagnostic pathway.
- What doesn't add up contradiction The two write-ups name different founding teams, five people in one account and two in the other, and both trace to the same company press release, so the operating detail behind the headline is thinner than the numbers suggest.
Next story · Invest · 11h ago
FSB's final AI guidance gives boards a role in four governance practices out of 12Confirmed2 publishers
Debt is 59% of the $220M headline [21], and the $130M from VerisFi Capital and Atempo Growth sits at 0.79 times an annualised run rate the company puts above $165M [3][18][22]. Neither write-up discloses pricing, covenants, or whether the facilities are drawn, and that gap matters more than the composition of the equity syndicate does, because a facility advanced against receivables and a covenanted term loan behave very differently in a quarter that misses.
The case for calling booking the binding constraint is Charlie Bullock's own: labs got a national front door decades ago through Quest Diagnostics and Labcorp, and imaging never did [14], while roughly 85% of US scans are still arranged by fax or telephone [11] in a market the company sizes above $100B [10]. What the product sells against that is the removal of per-facility plumbing, one API covering search, scheduling and results delivery [4], integrating into independent centres' own scheduling systems and electronic records [8]. Against a $100B denominator, a $165M run rate is 0.165% [24], which is the same thing Bullock means when he calls the company a small participant in the wider US market [20]. Or rather, the more interesting version of that number: more than 900,000 patients since 2021 [15][27] divided into the current run rate puts revenue per patient above $183 [25], a floor rather than an average, since the patient count is cumulative and global while the revenue is annualised and mostly American [17].
The failure mode here is specific. If the queue is scanners and radiologists rather than fax machines, a better router moves the wait instead of removing it, and the tell arrives as volume growing while the take thins, because Scan.com is bidding for slots at centres it does not own [8]. The sources name the frictions (offline booking, waits of weeks, idle scanner capacity, price dispersion between nearby centres for the same MRI [11][12][13]) without measuring how much of any given patient's wait each one accounts for, and all of it reaches a reader through the company itself: thesaasnews cites Scan.com's press release and dates the round 31 August 2026 [9].
Revenue has doubled once, from $85M last year to the run rate above $165M, a factor of 1.94 [19][18][23]. Doing it again means routing roughly another $165M of scans through the same network [26], and with $130M borrowed against it, that runs on a lender's calendar rather than an investor's.
What to watch
- Whether the next disclosed run rate above $165M arrives with a patient-volume figure beside it, which would turn the $183-per-patient floor into an actual average.
- Gross margin direction as the provider network expands, since paying up for slots is what capacity scarcity looks like in the accounts.
- Any move to own or lease imaging capacity rather than integrate with independent centres, which would concede that routing was not the whole problem.
Information, not investment advice. This story is general information about companies and markets, drawn from cited reporting. It is not a recommendation to buy, sell or hold any security; check the cited sources before acting.
Clarity's read
What the record supports and how the coverage leans. The claims behind it follow.
Reality
- Evidence34
- Adoption62
- Hype gap+22
- Incentives78
- Confidence48
Claim ledger
Ranked by verification strength, evidence, and original report placement.
- [1]
Scan.com raised $220 million in combined equity and debt financing as it expands its medical imaging platform across the United States.
- [2]
The $90 million equity round was led by Noteus Partners, with participation from Aviva, Concord Health Partners, YZR Capital and Oxford Capital.
- [3]
VerisFi Capital and Atempo Growth provided $130 million in debt facilities.
- [4]
Scan.com's platform brings search, scheduling and results delivery into one API, so healthcare companies can connect to imaging providers without building separate integrations for each facility.
- [5]
Scan.com uses AI to match referrals with providers based on availability, price and clinical specialisation, to manage scheduling and paperwork, and to route results to radiologists with relevant subspecialty expertise, combined with human care guides.
- [6]
The capital will support further expansion of Scan.com's US imaging provider network and continued investment in its API and agentic AI infrastructure, which automates patient routing, scan scheduling and diagnostic result delivery.
- [7]
Scan.com is headquartered in Atlanta, and the $220M round is described as a Series C, comprising a $90 million Series C equity round and $130 million in debt facilities.
- [8]
Scan.com's platform integrates with independent imaging centres' scheduling systems and electronic medical records, giving digital health providers and health plans access to a nationwide network through a single API.
- [9]
thesaasnews lists the funding date as August 31, 2026 and cites a Scan.com press release as its source.
- [10]
The US medical imaging market is valued at more than $100 billion, and much of the sector remains fragmented, expensive and dependent on offline processes.
- [11]
Around 85% of imaging scans are still booked through fax or telephone.
- [12]
Patients can wait weeks for appointments, while some imaging centres have unused scanner capacity.
- [13]
Scan.com says pricing can vary significantly between nearby centres for the same MRI scan.
- [14]
Co-founder and CEO Charlie Bullock said: "Labs got that decades ago with Quest Diagnostics and Labcorp. Imaging never did, and that is what we have built."
- [15]
More than 900,000 patients have accessed care through Scan.com's network globally.
- [16]
Scan.com operates in the UK and the United States, and expanded into the US in 2023.
- [17]
Scan.com currently generates most of its revenue in the United States, and about 80% of its workforce is based there.
- [18]
Scan.com surpassed a $165 million annualised revenue run rate after doubling revenue during the past year.
- [19]
Scan.com generated $85 million in revenue last year.
- [20]
Bullock said Scan.com remains a small participant in the wider US market, though the company aims to become a leading diagnostic imaging provider as its network expands.
- [21]
Debt accounts for 59% of the $220M raise.
- [22]
The $130M of debt equals 0.79 times the stated $165M annualised revenue run rate.
- [23]
The $165M run rate is 1.94 times last year's $85M of revenue.
- [24]
A $165M run rate is 0.165% of a market valued at more than $100 billion.
- [25]
The $165M run rate divided by more than 900,000 cumulative patients is about $183 per patient, a lower bound because the patient count is cumulative and global while revenue is annualised.
- [26]
Doubling again from the $165M run rate requires routing roughly another $165M of scans through the network, to about $330M.
- [27]
Scan.com was founded in 2021 by Bullock, Oliver Knight, Joe Daniels, Jasper Nissim and Khalid Latief, with an initial focus on imaging access and capacity in the UK.
- [28]
thesaasnews states Scan.com was founded in 2021 by Charlie Bullock and Oli White.
- [29]
Results are typically returned within 48 hours.
Sources
2 independent publishers whose own reporting we read for this story.
- thesaasnews.comScan.com Raises $220M Series C
1 article · September 4, 2026
- ventureburn.comScan.com Raises $220M to Expand US Medical Imaging
1 article · September 4, 2026
Topics and entities
Topics
- Venture Debt
- Healthcare API integration
- Agentic AI and tool use
- Diagnostic imaging
- Health Tech Funding
Entities
- Labcorp
- Quest Diagnostics
- Concord Health Partners